Skip to main content

Advertisement

Log in

Clinical significance of serum soluble Tie1 levels in patients with systemic sclerosis

  • Original Paper
  • Published:
Archives of Dermatological Research Aims and scope Submit manuscript

Abstract

Tie1 is an endothelial cell-specific tyrosine kinase receptor, which maintains vascular integrity and regulates angiogenesis via modulating angiopoietin/Tie2 signaling. Since the altered angiogenesis is closely related to the developmental process of systemic sclerosis (SSc), we herein investigated the clinical significance of serum soluble Tie1 (sTie1) levels and the expression levels of Tie1 in dermal microvascular endothelial cells (DMECs) in patients with SSc. Although serum sTie1 levels were comparable among total SSc, diffuse cutaneous SSc (dcSSc), limited cutaneous SSc (lcSSc), and healthy controls, SSc patients with decreased serum sTie1 levels had significantly shorter disease duration than those with serum sTie1 levels not decreased. In SSc patients with disease duration of >6 years, the prevalence of clinical symptoms associated with proliferative vasculopathy, such as digital ulcers, scleroderma renal crisis, and elevated right ventricular systolic pressure, was significantly higher in patients with decreased serum sTie1 levels than in those with serum sTie1 levels not decreased. In immunohistochemistry, Tie1 expression was reduced in DMECs of SSc patients with disease duration of <3 years compared with those of healthy controls. Collectively, in SSc patients with short disease duration, decreased serum sTie1 levels may reflect the down-regulation of Tie1 in DMECs. The decrease in serum sTie1 levels may serve as a marker of proliferative vasculopathy in SSc with disease duration of >6 years.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

References

  1. Abraham DJ, Krieg T, Distler J, Distler O (2009) Overview of pathogenesis of systemic sclerosis. Rheumatology (Oxford) 48(Suppl 3):iii3–iii7

    Article  CAS  Google Scholar 

  2. Asano Y (2010) Future treatments in systemic sclerosis. J Dermatol 37(1):54–70

    Article  PubMed  CAS  Google Scholar 

  3. Asano Y, Stawski L, Hant F, Highland K, Silver R, Szalai G, Watson DK, Trojanowska M (2010) Endothelial Fli1 deficiency impairs vascular homeostasis: a role in scleroderma vasculopathy. Am J Pathol 176(4):1983–1998

    Article  PubMed  CAS  Google Scholar 

  4. Augustin HG, Koh GY, Thurston G, Alitalo K (2009) Control of vascular morphogenesis and homeostasis through the angiopoietin-Tie system. Nat Rev Mol Cell Biol 10(3):165–177

    Article  PubMed  CAS  Google Scholar 

  5. Clements PJ, Lachenbruch PA, Seibold JR, Zee B, Steen VD, Brennan P, Silman AJ, Allegar N, Varga J, Massa M (1993) Skin thickness score in systemic sclerosis: an assessment of interobserver variability in 3 independent studies. J Rheumatol 20(11):1892–1896

    PubMed  CAS  Google Scholar 

  6. Fleming JN, Nash RA, McLeod DO, Fiorentino DF, Shulman HM, Connolly MK, Molitor JA, Henstorf G, Lafyatis R, Pritchard DK, Adams LD, Furst DE, Schwartz SM (2008) Capillary regeneration in scleroderma: stem cell therapy reverses phenotype? PLoS ONE 3(1):e1452

    Article  PubMed  Google Scholar 

  7. Fukuhara S, Sako K, Noda K, Zhang J, Minami M, Mochizuki N (2010) Angiopoietin-1/Tie2 receptor signaling in vascular quiescence and angiogenesis. Histol Histopathol 25(3):387–396

    PubMed  CAS  Google Scholar 

  8. Kämpfer H, Pfeilschifter J, Frank S (2001) Expressional regulation of angiopoietin-1 and -2 and the tie-1 and -2 receptor tyrosine kinases during cutaneous wound healing: a comparative study of normal and impaired repair. Lab Invest 81(3):361–373

    Article  PubMed  Google Scholar 

  9. Kim WU, Min SY, Cho ML, Hong KH, Shin YJ, Park SH, Cho CS (2005) Elevated matrix metalloproteinase-9 in patients with systemic sclerosis. Arthritis Res Ther 7(1):R71–R79

    Article  PubMed  CAS  Google Scholar 

  10. LeRoy E, Black C, Fleischmajer R, Jablonska S, Krieg T, Medsger TJ, Rowell N, Wollheim F (1988) Scleroderma (systemic sclerosis): classification, subsets and pathogenesis. J Rheumatol 15(2):202–205

    PubMed  CAS  Google Scholar 

  11. Lobov IB, Brooks PC, Lang RA (2002) Angiopoietin-2 displays VEGF-dependent modulation of capillary structure and endothelial cell survival in vivo. Proc Natl Acad Sci USA 99(17):11205–11210

    Article  PubMed  CAS  Google Scholar 

  12. Loughna S, Sato TN (2001) A combinatorial role of angiopoietin-1 and orphan receptor TIE1 pathways in establishing vascular polarity during angiogenesis. Mol Cell 7(1):233–239

    Article  PubMed  CAS  Google Scholar 

  13. Manetti M, Guiducci S, Ibba-Manneschi L, Matucci-Cerinic M (2010) Mechanisms in the loss of capillaries in systemic sclerosis: angiogenesis versus vasculogenesis. J Cell Mol Med 14(6A):1241–1254

    Article  PubMed  CAS  Google Scholar 

  14. Marron MB, Singh H, Tahir TA, Kavumkal J, Kim HZ, Koh GY, Brindle NP (2007) Regulated proteolytic processing of Tie1 modulates ligand responsiveness of the receptor-tyrosine kinase Tie2. J Biol Chem 282(42):30509–30517

    Article  PubMed  CAS  Google Scholar 

  15. Mould TL, Roberts-Thomson PJ (2000) Pathogenesis of telangiectasia in scleroderma. Asian Pac J Allergy Immunol 18(4):195–200

    PubMed  CAS  Google Scholar 

  16. Noda S, Asano Y, Aozasa N, Akamata K, Yamada D, Masui Y, Tamaki Z, Kadono T, Sato S (2011) Serum Tie2 levels: clinical association with microangiopathies in patients with systemic sclerosis. J Eur Acad Dermatol Venereol 25(12):1476–1479

    Article  PubMed  CAS  Google Scholar 

  17. American Rheumatism Association Diagnostic and Therapeutic Criteria Committee (1980) Preliminary criteria for the classification of systemic sclerosis (scleroderma). Subcommittee for scleroderma criteria of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee. Arthritis Rheum 23(5):581–590

    Article  Google Scholar 

  18. Puri MC, Rossant J, Alitalo K, Bernstein A, Partanen J (1995) The receptor tyrosine kinase TIE is required for integrity and survival of vascular endothelial cells. EMBO J 14(23):5884–5891

    PubMed  CAS  Google Scholar 

  19. Sato TN, Tozawa Y, Deutsch U, Wolburg-Buchholz K, Fujiwara Y, Gendron-Maguire M, Gridley T, Wolburg H, Risau W, Qin Y (1995) Distinct roles of the receptor tyrosine kinases Tie-1 and Tie-2 in blood vessel formation. Nature 376(6535):70–74

    Article  PubMed  CAS  Google Scholar 

  20. Shah AA, Wigley FM, Hummers LK (2010) Telangiectases in scleroderma: a potential clinical marker of pulmonary arterial hypertension. J Rheumatol 37(1):98–104

    Article  PubMed  Google Scholar 

  21. Thomas M, Augustin HG (2009) The role of the Angiopoietins in vascular morphogenesis. Angiogenesis 12(2):125–137

    Article  PubMed  CAS  Google Scholar 

  22. Trojanowska M (2010) Cellular and molecular aspects of vascular dysfunction in systemic sclerosis. Nat Rev Rheumatol 6(8):453–460

    Article  PubMed  CAS  Google Scholar 

  23. Yabkowitz R, Meyer S, Black T, Elliott G, Merewether LA, Yamane HK (1999) Inflammatory cytokines and vascular endothelial growth factor stimulate the release of soluble tie receptor from human endothelial cells via metalloprotease activation. Blood 93(6):1969–1979

    PubMed  CAS  Google Scholar 

Download references

Acknowledgments

We thank Tamami Kaga and Yoshiko Ito for the technical help in immunohistochemistry. This work was supported by a grant for Research on Intractable Diseases from the Ministry of Health, Labor, and Welfare of Japan.

Conflict of interest

The authors declare that they have no conflict of interest.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Yoshihide Asano.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Noda, S., Asano, Y., Aozasa, N. et al. Clinical significance of serum soluble Tie1 levels in patients with systemic sclerosis. Arch Dermatol Res 305, 325–331 (2013). https://doi.org/10.1007/s00403-012-1307-4

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00403-012-1307-4

Keywords

Navigation